Epidermolysis bullosa simplex due to KRT5 mutations: mutation-related differences in cellular fragility and the protective effects of trimethylamine N-oxide in cultured primary keratinocytes.
BACKGROUND
Epidermolysis bullosa simplex (EBS) is a mechanobullous skin fragility disease characterized by cytolysis of basal keratinocytes and intraepidermal blistering often caused by mutations in keratin genes (KRT5 or KRT14). No remedies exist for these disorders presenting a need for development of novel therapies.


OBJECTIVE
To identify new genotype-phenotype relationships in vivo and in cultured primary EBS keratinocytes in vitro, and to study the cytoskeletal stabilizing effects of trimethylamine N-oxide (TMAO) in heat-stressed EBS cells.


METHODS
Genomic DNA and cDNA samples from three Swedish patients with EBS were analysed for keratin mutations. Primary EBS keratinocyte cultures were established, heat stressed with and without added TMAO, followed by evaluation of cellular fragility.


RESULTS
In addition to the previously reported KRT5 mutation (V186L) in one patient, two patients were found to have a novel I183M and recurrent E475G replacements in KRT5. Cultured EBS keratinocytes did not exhibit keratin aggregates or cell loss, except in the patient with the p.I183M mutation who showed 3% aggregates and 2% cell loss. Upon transient heat stress the number of aggregate-containing cells increased to 21%, 27% and 13%, respectively, in the p.I183M, p.E475G and p.V186L mutant cells. Interestingly, pretreatment with TMAO prior to heat stress, dose dependently reduced the number of aggregate-containing cells and cell loss.


CONCLUSIONS
These results revealed a genotype-phenotype correlation in EBS keratinocytes upon heat stress and suggest protein stabilization as a new therapeutic strategy.
Department of Medical Sciences/Dermatology and Venereology, Uppsala University Hospital, Uppsala 751 85, Sweden.
J C
JC
Chamcheu
M
M
Virtanen
H
H
Navsaria
P E
PE
Bowden
A
A
Vahlquist
H
H
Törmä
D000328:Adult; D016923:Cell Death / Q000187:drug effects / Q000235:genetics; D002478:Cells, Cultured; D004252:DNA Mutational Analysis / Q000379:methods; D016110:Epidermolysis Bullosa Simplex / Q000235:genetics* / Q000473:pathology; D005260:Female; D005838:Genotype; D018869:Heat-Shock Response / Q000187:drug effects; D006801:Humans; D053555:Keratin-5 / Q000235:genetics*; D015603:Keratinocytes / Q000187:drug effects* / Q000473:pathology; D008297:Male; D008744:Methylamines / Q000494:pharmacology*; D008875:Middle Aged; D020125:Mutation, Missense; D016877:Oxidants / Q000494:pharmacology; D010641:Phenotype
C503940:KRT5 protein, human; D053555:Keratin-5; D008744:Methylamines; D016877:Oxidants; C005855:trimethyloxamine